We are committed to meet the highest standards of ethics and corporate compliance as specified in the Mitsubishi Tanabe Pharma Group Mission, Vision 30 and Corporate Behaviour Charter.

Mission

Creating hope for all facing illness

Vision 30

Be a healthcare company that delivers optimal therapy to each individual..

Corporate Behaviour Charter

We maintain the highest ethical standards, place top priority on fairness and integrity in all activities, and act in accordance with the following guidelines.

Pride and Sense of Mission

As people involved in the creation of pharmaceuticals, we work with pride and a sense of mission as we endeavour to research and develop pharmaceuticals that are needed by society and to ensure product safety and quality.

Challenge and Innovation

With acute sensitivity and a broad perspective, we focus on our future direction, decisively take on the challenge of meeting higher goals, and strive to create innovative value.

Trust and Collaboration

We promote free and open communication to understand and respect each other, and collaborate with mutual trust to maximize our results.

Harmonious Coexistence with Society

We work to achieve harmonious coexistence with society by acting with consideration for local communities and the environment.

 

Declaration of Compliance

1. We conduct our business with the highest ethical standards and in a professional manner as a global healthcare company.

2. We respect human rights, and promote safe and healthy working environments.

3. We comply with legal requirements and regulations that apply to our businesses and corporate activities.

4. We work actively to protect the global environment and strive to realize harmonious co-existence of the Company and society.

5. We strive to trade and transact business in a fair manner at all times.

6. We appropriately manage company information and data, and work to ensure that company information and data is disclosed in a timely and reasonable manner.

7. We appropriately manage and efficiently use company assets.